Prelude Therapeutics shares owned by Citigroup
Quarter-by-quarter ownership of Prelude Therapeutics (PRLD) shares owned by Citigroup
from 13F filings
Historical chart of Citigroup investment in Prelude Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Prelude Therapeutics held by Citigroup consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Prelude Therapeutics by Citigroup
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-12-31 | $13k | 10k | 1.27 |
| 2024-09-30 | $20k | 9.7k | 2.07 |
| 2024-06-30 | $12k | 3.0k | 3.82 |
| 2024-03-31 | $13k | 2.8k | 4.76 |
| 2023-12-31 | $9.1k | 2.1k | 4.27 |
| 2023-09-30 | $1.6k | 526 | 3.09 |
| 2023-03-31 | $403k | 71k | 5.70 |
| 2022-12-31 | $363k | 60k | 6.04 |
| 2022-09-30 | $56k | 8.5k | 6.56 |
| 2021-12-31 | $51k | 4.1k | 12.51 |
| 2021-03-31 | $2.6M | 61k | 43.34 |
| 2020-12-31 | $124k | 1.7k | 71.63 |